Download to read offline
Use of and impact of EULabCap monitoring in Austria
This document discusses the use and impact of EULabCap monitoring in Austria. It notes that unlike many EU countries, Austria did not require clinical microbiology laboratories to be licensed or obtain biosafety authorization, and there was no monitoring of diagnostic testing guidelines for key diseases. Contribution of national reference laboratories to national surveillance varied by disease and was below the EU average. Molecular typing data on pilot pathogens were no longer reported to the EU surveillance database and antimicrobial resistance characterization was only performed upon request, not as part of monitoring surveys. Overall compliance with EU standards was lower than most other EU nations.
Use of and impact of EULabCap monitoring in Austria
- 1. Austrian Agency forHealth and Food Safety www.ages.at Franz Allerberger , NMFP Austria (15 min) Use of and impact of EULabCap monitoring in Austria
- 2.
- 3.
- 4.
- 5.
- 6. www.ages.at Individual country report- NOT open access
- 7.
- 8. www.ages.at Individual country report- NOT open access
- 9.
- 10. www.ages.at Individual country report- NOT open access
- 11. www.ages.at KRANKENANSTALT mikrobiologische Untersuchungen im Jahr2016 Belegstage im Jahr 2016 Kommentar 101 253 46.800 103 104 3.781 520.573 105 18 21.250 106 30 33.021 107 2.086 304.898 108 29 33.719UKH 110 112 113 0 147.004Reha-Zentrum 116 432 37.710 118 18 44.490UKH 119 127 202 45.842 128 698 100.730 134 629 87.955 135 138 746 45.727KH mit chronisch-entzündlicher Darmambulanz 139 25 57.354 142 161 24.307 143 0 48.689Rehaklinik/Sonderklinik 144 145 29 46.586 146 247 52.742 147 144 65.452 149 150 4.521 511.384 151 1.101 121.589 152 153 1.078 184.802 Gesamt 16.228 2.582.624 DATA PROVIDED BY PROF. PRESTERL (Ref.-Centre for Nosocomial Infections)
- 12. www.ages.at Individual country report- NOT open access
- 13.
- 14. www.ages.at Individual country report- NOT open access
- 15. www.ages.at Individual country report- NOT open access
- 16. www.ages.at 16 “That’s howevaluations look just when comparing apples to pears! In the case of 2.24 Serogroup STEC: Stool samples sent to the reference center versus STEC isolates sent to the reference center.”
- 17. www.ages.at 17 Individual countryreport - NOT open access
- 18.
- 20. For attention: Unlikethe majority of EU countries, clinical microbiology laboratories were not required by law to obtain a licencing nor biosafety authorisation. There was no monitoring of compliance of diagnostic testing guidelines for key diseases. Contribution of national reference laboratories to national surveillance varied by disease and was overall below EU average. Molecular typing data on pilot EU molecular surveillance pathogens were no longer reported to EU surveillance database TESSy. Antimicrobial resistance characterization for carbapenemase- and ESBL-producing Enterobacteriaceae and methicillin- resistant Staphylococcus aureus was performed only upon request from diagnostic laboratories and not part of monitoring surveys. EULabCap country profile AUSTRIA Report on 2016 data Version 1, 19 December 2017 Individual country report - NOT open access
- 21.
- 22.
- 23.